期刊文献+

不同剂量厄贝沙坦治疗高原心脏病伴心力衰竭临床疗效分析 被引量:3

下载PDF
导出
摘要 目的:探讨不同剂量厄贝沙坦治疗高原心脏病伴心力衰竭的临床疗效和安全性。方法:通过给予两组患者不同剂量厄贝沙坦,对其结果进行分析。结果:两组患者的心功能、血压和Tei指数得到了很好的控制,且服用剂量较大的B组效果优于A组,(P<0.05)。结论:厄贝沙坦在改善心功能方面具有非常好的效果,但一定要把握好服用剂量,并对患者的血压以及不良反应进行监测,及时结合患者的实际情况调整服用剂量。
作者 谭裕尧
机构地区 甘孜州人民医院
出处 《亚太传统医药》 2013年第10期177-178,共2页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献4

二级参考文献25

  • 1中国居民营养与健康现状[J].中国心血管病研究,2004,2(12):919-922. 被引量:495
  • 2刘国仗,于汇民.高血压治疗策略的演化[J].中华心血管病杂志,2006,34(7):668-670. 被引量:46
  • 3黄峻.慢性心力衰竭临床研究的新趋势[J].中华心血管病杂志,2007,35(7):593-594. 被引量:44
  • 4燕声满.厄贝沙坦与硝苯地平联用治疗原发性高血压50例临床观察[J].中国慢性病预防与控制,2007,15(5):452-453. 被引量:16
  • 5Flather MD,Yu suf S,Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:a systematic overview of data from individual patients.ACE-Inhibitor Myocardial Infarction Collaborative Group[J].The Lancet,2000,(9215):1575-1581.
  • 6Struthers AD. Aldosterone escape during ACE inhibit or therapy in chronic heart failure[J].European Heart Journal,1995,(N):103-106.
  • 7Petrie MC,Padmanabhan N,McDonald JE. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin Ⅱ generation in resistance arteries from patients with heart failure and coronary heart disease[J].Journal of the American College of Cardiology,2001,(04):1056-1061.doi:10.1016/S0735-1097(01)01111-1.
  • 8Tonkon M,Awan N,Niazi I. A study of the efficacy and safety of irbesartan in combination with conventional therapy,including ACE inhibitors,inheart failure.Irbesartan Heart Failure Group[J].International Journal of Clinical Practice,2000,(01):11-4,16-8.
  • 9Kum LC,Yip GW,Lee PW. Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure[J].International Journal of Cardiology,2008,(01):16-21.doi:10.1016/j.ijcard.2007.02.016.
  • 10McMrray JJ,Otergren J,Swedbery K. Effects of cardesartan in patients with chronic heart failure and reduced left-ventricular systonlic function taking angiotensin-converting-enzyme inhibitors:The CHARM-Added trial[J].The Lancet,2003,(9386):767-771.

共引文献25

同被引文献56

  • 1吴天一.确立我国高原病诊断标准的综合评论[J].高原医学杂志,1995,5(3):3-8. 被引量:23
  • 2关于统一使用慢性高原(山)病“青海标准”的决定[J].高原医学杂志,2007,17(1):1-2. 被引量:70
  • 3Gonzales G F,Rubio J, Gasco M. Chronic mountain sicknessscore was related with health status score but not with hemo-globin levels at high altitudes[ J]. Respir Physiol Neurobiol,2013,188(2) : 152 - 160. DOI: 10.1016/j. resp. 2013.06.006.
  • 4Leon-Velarde F, Maggiorini M, Reeves J T, ef al. Consensusstatement on chronic and subacute high altitude diseases[ J].High Alt Med Biol, 2005, 6 (2): 147 - 157. DOI: 10.1089/ham. 2005.6. 147.
  • 5Ward M. High altitude deterioration[ J]. Proc R Soc Lond,B,Biol Sci,1954,143(910) : 40-42.
  • 6Jiang C,Chen J, Liu F,et al. Chronic mountain sickness inChinese Han males who migrated to the Qinghai-Tibetan plat-eau :application and evaluation of diagnostic criteria for chro-nic mountain sickness [ J ]. BMC Public Health, 2014,14:701. DOI: 10.1186/1471-2458-14-701.
  • 7Guan W, Ga Q, Li R, et al. Sleep disturbances in long-termimmigrants with chronic mountain sickness : a comparison withhealthy immigrants at high altitude [ J ]. Respir Physiol Neuro-biol, 2015,206: 4 - 10. DOI: 10. 1016/j. resp. 2014. 11.007.
  • 8Dedobbeleer C, Hadefi A, Pichon A, et al. Left ventricularadaptation to high altitude : speckle tracking echocardiographyin lowlanders, healthy highlanders and highlanders with chro-nic mountain sickness [ J ]. Int J Cardiovasc Imaging, 2015,31(4) : 743 -752. DOI: 10.1007/sl0554-015-0614-l.
  • 9Villafuerte F C, Macarlupu J L,Anza-Ramirez C, et al.Decreased plasma soluble erythropoietin receptor in high-al-titude excessive erythrocytosis and chronic mountain sickness[J]. J Appl Physiol (1985),2014,117(11): 1356 -1362. DOI: 10. 1152/japplphysiol. 00619. 2014.
  • 10Espinoza J R,Alvarez G, Leon-Velarde F, et al. Vascularendothelial growth factor-A is associated with chronic moun-tain sickness in the Andean population [ J]. High Alt MedBiol, 2014, 15 (2): 146 - 154. DOI: 10. 1089/ham.2013.1121.

引证文献3

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部